selected scholarly activity
-
academic article
- A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research. BMC Medical Research Methodology. 18:9. 2018
- Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL). Health and Quality of Life Outcomes. 16:78. 2018
- Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Heart Lung and Circulation Asia Pacific Heart Journal. 27:666-682. 2018
- Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings. Acta Paediatrica, International Journal of Paediatrics. 107:534-537. 2018
- Enhancing research publications and advancing scientific writing in health research collaborations: sharing lessons learnt from the trenches. Journal of Multidisciplinary Healthcare. Volume 11:245-254. 2018
- Exploring the characteristics, global distribution and reasons for retraction of published articles involving human research participants: a literature survey. Journal of Multidisciplinary Healthcare. Volume 11:39-47. 2018
- An overview of osteoporosis and frailty in the elderly. BMC Musculoskeletal Disorders. 18:46. 2017
- The premarket assessment of the cost-effectiveness of a predictive technology “Straticyte™” for the early detection of oral cancer: a decision analytic model. Health Economics Review. 7:35. 2017
- A practical methodology for disaggregating the drivers of drug costs using administrative data. Journal of Population Therapeutics and Clinical Pharmacology. 24:16-24. 2017
- Relationship between hyperbaric oxygen therapy and quality of life in participants with chronic diabetic foot ulcers: data from a randomized controlled trial. Acta Diabetologica. 54:823-831. 2017
- Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets. Annals of Internal Medicine. 167:JC10-JC10. 2017
- Modifying the Phenotypic Frailty Model in Predicting Risk of Major Osteoporotic Fracture in the Elderly. Journal of the American Medical Directors Association. 18:414-419. 2017
- An introduction to multiplicity issues in clinical trials: the what, why, when and how. International Journal of Epidemiology. 46:dyw320-dyw320. 2017
- State of reporting of primary biomedical research: a scoping review protocol. BMJ Open. 7:e014749-e014749. 2017
- In older adults with COPD, new opioid use was linked to increased risk for respiratory and all-cause mortality. Annals of Internal Medicine. 166:JC11-JC11. 2017
- DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS. International Journal of Technology Assessment in Health Care. 33:261-269. 2017
- Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults. Canadian Journal of Psychiatry. 62:11-23. 2017
- Erratum to: Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respiratory Research. 17:128. 2016
- Knowledge Translation Strategy to Reduce the Use of Potentially Inappropriate Medications in Hospitalized Elderly Adults. Journal of the American Geriatrics Society. 64:2487-2494. 2016
- Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis. Annals of Intensive Care. 6:18. 2016
- Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respiratory Research. 17:80. 2016
- Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials. European Journal of Epidemiology. 31:541-561. 2016
- Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis.. Clinical and Investigative Medicine. 39:E48-E62. 2016
- Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study. Clinical Lymphoma, Myeloma and Leukemia. 16:18-28.e4. 2016
- Aneurysmal subarachnoid hemorrhage prognostic decision-making algorithm using classification and regression tree analysis. Surgical Neurology International. 7:73-73. 2016
- Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case. PLoS ONE. 11:e0160713-e0160713. 2016
- Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension. Journal of the American Society of Hypertension. 10:55-69.e1. 2016
- Clinical outcome prediction in aneurysmal subarachnoid hemorrhage - Alterations in brain-body interface. Surgical Neurology International. 7:527-527. 2016
- Cost effectiveness of a systematic guidelines-based approach to the prevention and management of vascular disease in a primary care setting. International Journal of Cardiology. 203:893-899. 2016
- Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol. BMJ Open. 5:e009518-e009518. 2015
- Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients. Medicine (United States) Medicine. 94:e1479-e1479. 2015
- Effect of green tea supplementation on blood pressure among overweight and obese adults. Journal of Hypertension. 33:243-254. 2015
- Development and Validation of the McMaster Prescribing Competency Assessment for Medical Trainees (MacPCA).. Journal of Population Therapeutics and Clinical Pharmacology. 22:e173-e178. 2015
- Pathophysiologic mechanisms of brain-body associations in ruptured brain aneurysms: A systematic review. Surgical Neurology International. 6:136-136. 2015
- Systematic review of clinical prediction tools and prognostic factors in aneurysmal subarachnoid hemorrhage. Surgical Neurology International. 6:135-135. 2015
- Effect of green tea supplementation on blood pressure among overweight and obese adults: a protocol for a systematic review. BMJ Open. 4:e004971-e004971. 2014
- Household income and LDL-C goal attainment in patients with diabetes and dyslipidemia in a Canadian dataset.. Clinical and Investigative Medicine. 37:E47-E52. 2014
- Patient-specific academic detailing for smoking cessation: feasibility study.. Canadian Family Physician. 60:e16-e23. 2014
- Clinical Outcome Prediction in Aneurysmal Subarachnoid Hemorrhage Using Bayesian Neural Networks with Fuzzy Logic Inferences. Computational and Mathematical Methods in Medicine. 2013:1-10. 2013
- Evidence against the Involvement of Chronic Cerebrospinal Venous Abnormalities in Multiple Sclerosis. A Case-Control Study. PLoS ONE. 8:e72495-e72495. 2013
- Understanding how a dental infection may spread to the brain: case report.. Journal of the Canadian Dental Association. 79:d9. 2013
- Hypnotic drugs were associated with increased risk for mortality. Annals of Internal Medicine. 156:JC6-JC6. 2012
- Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.. Journal of Population Therapeutics and Clinical Pharmacology. 19:e166-e178. 2012
- Determing the threshold of acceptability of an ICER when natural health units are used.. Journal of Population Therapeutics and Clinical Pharmacology. 19:e234-e238. 2012
- A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials. Investigational New Drugs. 29:1013-1020. 2011
- Relative risk and odds ratio data are still portrayed with inappropriate scales in the medical literature. Journal of Clinical Epidemiology. 63:1045-1047. 2010
- Correction to the Relative Risk Calculation for Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis. Radiology. 255:307-308. 2010
- An evaluation of pharmacist and health food store retailer's knowledge regarding potential drug interactions associated with St. John's wort.. Journal of Population Therapeutics and Clinical Pharmacology. 17:e57-e63. 2010
- Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Effectiveness and Resource Allocation. 8:14-14. 2010
- Self-reported use of natural health products: A cross-sectional telephone survey in older Ontarians. American Journal of Geriatric Pharmacotherapy. 7:383-392. 2009
- Goal attainment for multiple cardiovascular risk factors in community-based clinical practice (a Canadian experience). Journal of Evaluation in Clinical Practice. 15:212-216. 2009
- Ethics of Expedited Partner Therapy. AMA journal of ethics. 10:708-718. 2008
- Emergency Department and Walk-in Clinic Use in Models of Primary Care Practice with Different After-Hours Accessibility in Ontario.. Healthcare Policy. 4:73-88. 2008
- GPs' approach to insulin prescribing in older patients: a qualitative study. British Journal of General Practice. 58:569-575. 2008
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline. Annals of Internal Medicine. 148:379-379. 2008
- Do patients' expectations influence their use of medications? Qualitative study.. Canadian Family Physician. 54:384-393. 2008
- Clinical and Economic Effects of a Therapeutic Substitution Policy for Proton Pump Inhibitors in Aboriginal Patients in Northern Communities in Canada???s Northwest Territories. Disease Management and Health Outcomes. 16:175-182. 2008
- Medical residents' and students' attitudes towards herbal medicines: a pilot study.. Journal of Population Therapeutics and Clinical Pharmacology. 15:e1-e4. 2008
- Long-term persistence with orlistat and sibutramine in a population-based cohort. International Journal of Obesity. 31:1567-1570. 2007
- Outcomes of Dosage Adjustments Used to Manage Antiretroviral Drug Interactions. Clinical Infectious Diseases. 45:933-936. 2007
- Teaching musculoskeletal ultrasound in the undergraduate medical curriculum. Medical Education British journal of medical education. 41:517-518. 2007
- Potential Interactions Between Pharmaceuticals and Natural Health Products in Canada. Journal of Clinical Pharmacology. 47:249-258. 2007
- "I take what I think works for me": a qualitative study to explore patient perception of diabetes treatment benefits and risks.. Journal of Population Therapeutics and Clinical Pharmacology. 14:e251-e259. 2007
- Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension. Journal of Clinical Epidemiology. 60:1.e1-1.e11. 2007
- Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care.. Clinical and Investigative Medicine. 30:E63-E69. 2007
- A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics. Journal of Evaluation in Clinical Practice. 12:463-470. 2006
- Pharmacovigilance in a genomic era. Pharmacogenomics Journal. 6:158-161. 2006
- Sex differences in hospital admissions from emergency departments in asthmatic adults: a population-based study. Annals of Allergy, Asthma and Immunology. 96:666-672. 2006
- Community-based evaluation of etanercept in patients with rheumatoid arthritis.. Journal of Rheumatology. 33:665-670. 2006
- Is Fetal Gender Associated with Emergency Department Visits for Asthma During Pregnancy?. Journal of Asthma The Journal of asthma research. 43:293-299. 2006
- Natural health product use in Canada: analysis of the National Population Health Survey.. Journal of Population Therapeutics and Clinical Pharmacology. 13:e240-e250. 2006
- Patient Characteristics Associated with Nocturnal Emergency Department Visits for Asthma. Journal of Asthma The Journal of asthma research. 43:469-475. 2006
- Using Patient-Oriented Evidence-Based Information Guides in Practice: The Family Physician and Community Pharmacist Perspective. Drug Information Journal. 40:61-67. 2006
- Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?. BMC Endocrine Disorders. 5:1. 2005
- Effect of Gender, Age, and Severity of Asthma Attack on Patterns of Emergency Department Visits due to Asthma by Month and Day of the Week. European Journal of Epidemiology. 20:947-956. 2005
- Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.. Journal of Population Therapeutics and Clinical Pharmacology. 12:e254-e263. 2005
- A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocrine Disorders. 4:2. 2004
- The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.. Canadian Journal of Cardiology. 20:31-40. 2004
- The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.. Canadian Journal of Cardiology. 20:41-54. 2004
- Providing evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?. Health Expectations. 6:281-289. 2003
- Understanding drug-herb interactions. Pharmacoepidemiology and Drug Safety. 12:427-430. 2003
- Drug-Herb Interaction Among Commonly Used Conventional Medicines: A Compendium for Health Care Professionals. American Journal of Therapeutics. 10:163-169. 2003
- Validity of self-reported prescription drug insurance coverage.. Health Reports. 14:35-46. 2003
- Decision-making by healthcare payers. Respiratory Medicine. 96:S31-S38. 2002
- Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis. American Journal of Medicine. 112:642-646. 2002
- The 2001 Canadian Hypertension Recommendations--What is new and what is old but still important.. Canadian Journal of Cardiology. 18:591-603. 2002
- The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.. Canadian Journal of Cardiology. 18:604-624. 2002
- The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.. Canadian Journal of Cardiology. 18:625-641. 2002
- Valuing Knowledge and the Knowledge of Values: Understanding Guideline- Incongruent Prescribing. Journal of Clinical Pharmacology. 42:475-476. 2002
- Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.. Journal of Population Therapeutics and Clinical Pharmacology. 9:199-202. 2002
- What patients want to know about their medications. Canadian Family Physician. 48:104-110. 2002
- What patients want to know about their medications. Focus group study of patient and clinician perspectives.. Canadian Family Physician. 48:104-110. 2002
- Evaluation of the Association Between St. John's Wort and Elevated Thyroid-Stimulating Hormone. Pharmacotherapy. 21:1574-1578. 2001
- The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.. Canadian Journal of Cardiology. 17:1249-1263. 2001
- The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.. Canadian Journal of Cardiology. 17:543-559. 2001
- Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease.. Canadian Journal of Cardiology. 17:270-276. 2001
- The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.. CMAJ. 164:517-522. 2001
- Thwarting sore throats.. CMAJ. 164:461. 2001
- The place for prescribing guidelines and the means of their dissemination.. Journal of Population Therapeutics and Clinical Pharmacology. 8 Suppl A:29A-33A. 2001
- A novel process for updating recommendations for managing hypertension: rationale and methods.. Canadian Journal of Cardiology. 16:1094-1102. 2000
- An algorithm to aid in the investigation of thalassemia trait in multicultural populations.. Archives of pathology Archives of Pathology and Laboratory Medicine. 124:1320-1323. 2000
- Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)?. Journal of Clinical Epidemiology. 53:888-894. 2000
- Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy. Pharmacoepidemiology and Drug Safety. 9:367-370. 2000
- Risk of congenital malformations associated with treatment of asthma during early pregnancy. The Lancet. 355:119-119. 2000
- The canadian society for clinical pharmacology in the post-royal college era. Journal of Population Therapeutics and Clinical Pharmacology. 7:20-21. 2000
- Promoting Optimal Antibiotic Therapy for Otitis Media Using Commercially Sponsored Evidence-Based Detailing: A Prospective Controlled Trial. Drug Information Journal. 33:1067-1077. 1999
- Interpreting Meta-Analyses of Pharmacologic Interventions: The Pitfalls and How to Identify Them. Pharmacotherapy. 19:741-746. 1999
- Can the health care system buy better antibiotic prescribing behaviour?. CMAJ. 160:1023-1024. 1999
- In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.. Journal of Pharmacology and Experimental Therapeutics. 284:493-499. 1998
- A Prospective Comparison of Four Study Designs Used in Assessing Safety and Effectiveness of Drug Therapy in Hypertension Management. American Journal of Hypertension. 10:1191-1200. 1997
- Cost-Benefit Analyses in the Health-Care Literature: Don't Judge a Study by Its Label. Journal of Clinical Epidemiology. 50:813-822. 1997
- Users' guides to the medical literature .13. How to use an article on economic analysis of clinical practice .B. What are the results and will they help me in caring for my patients?. JAMA - Journal of the American Medical Association. 277:1802-1806. 1997
- Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA - Journal of the American Medical Association. 277:1802-1806. 1997
- Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA - Journal of the American Medical Association. 277:1552-1557. 1997
- Cost effectiveness of AlternativeHelicobacter pyloriEradication Strategies in the Management of Duodenal Ulcer. Canadian Journal of Gastroenterology. 11:323-331. 1997
- The Evaluation of Various Mathematical RBC Indices and Their Efficacy in Discriminating Between Thalassemic and Non-Thalassemic Microcytosis. American Journal of Clinical Pathology. 106:201-205. 1996
- Developing a Canadian prescribing practices network. CMAJ. 154:1325-1331. 1996
- Developing a Canadian prescribing practices network. Network Development Committee of the Canadian Prescribing Practices Network Project.. CMAJ. 154:1325-1331. 1996
- Experience in The Development of a Postmarketing Surveillance Network: The Pharmacy Medication Monitoring Program. Annals of Pharmacotherapy. 29:1208-1213. 1995
- Health-related quality of life in patients with major depression who are treated with moclobemide.. Journal of Clinical Psychopharmacology. 15:60S-67S. 1995
- USERS GUIDES TO THE MEDICAL LITERATURE .5. HOW TO USE AN ARTICLE ABOUT PROGNOSIS. JAMA - Journal of the American Medical Association. 272:234-237. 1994
- USERS GUIDES TO THE MEDICAL LITERATURE .4. HOW TO USE AN ARTICLE ABOUT HARM. JAMA - Journal of the American Medical Association. 271:1615-1619. 1994
- Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA - Journal of the American Medical Association. 271:1615-1619. 1994
- USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS. JAMA - Journal of the American Medical Association. 271:703-707. 1994
- The effect of food or sucralfate on the bioavailability of S(+) and R(-) enantiomers of ibuprofen.. Journal of Clinical Pharmacology. 32:1110-1114. 1992
- A guide for assessing pharmacoepidemiologic studies.. Pharmacotherapy. 12:232-237. 1992
- Acute myocardial infarction associated with cocaine withdrawal.. CMAJ. 144:1139-1140. 1991
- Ferioterol and fatal asthma. The Lancet. 337:186-187. 1991
- RATIONAL THERAPY TO PREVENT NSAID-ASSOCIATED GASTRIC AND DUODENAL INJURY. Hospital Formulary. 25:1160-&. 1990
- Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol. Clinical Pharmacology and Therapeutics. 43:39-48. 1988
-
conference paper
- Item reduction and validation of the Chinese version of Diabetes Quality-of-Life Measure (DQOL). Quality of Life Research. 124-125. 2017
- Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial. European Journal of Clinical Pharmacology. 1237-1245. 2017
- Gender Gap for LDL-C Goal Achievement Amongst Patients with Diabetes and Dyslipidemia. Endocrine Reviews Recent Progress in Hormone Research. 2014
- Previous Exposure to Statin and Adherence to Lipid-Lowering Therapeutics. Endocrine Reviews Recent Progress in Hormone Research. 2014
- Survival crossover adjustment and cost effectiveness analysis: An empirical and methodological review with application. Value in Health. A202-A202. 2014
- Potential for Selection Bias in the Context of a Restriction Drug Access Program: The Case of Atomoxetine in Quebec, Canada. Pharmacoepidemiology and Drug Safety. 381-381. 2013
- Excite – A New Collaborative Model Of Pre-Market Evaluation Of Health Technologies. Value in Health. A264-A264. 2013
- DABIGATRAN PERSISTENCE IN THE COMMUNITY SETTING IN CANADA. Clinical Pharmacology and Therapeutics. S58-S58. 2013
- A REVIEW OF DUR METHODS REPORTED IN THE LITERATURE. Clinical Pharmacology and Therapeutics. S14-S15. 2011
- PND46 A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF CIDP. Value in Health. A374-A374. 2009
- PSY30 COST-UTILITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMPARED WITH CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN CANADA. Value in Health. A380-A381. 2009
- The Effect of Metabolic Syndrome on Global Cardiovascular Risk Reduction in High-Risk Patients with Dyslipidemia on Pharmacotherapy. Circulation. E343-E343. 2009
- CONCOMITANT USE OF CARDIOVASCULAR RELATED MEDICATIONS IN DIABETIC PATIENTS RECEIVING ROSIGLITAZONE.. Clinical Pharmacology and Therapeutics. S16-S17. 2009
- Associations between vitamin D status and asthma severity. Pediatric Research. 452-452. 2008
- Concomitant use of cardiovascular related medications in diabetic patients receiving rosiglitazone. Pharmacoepidemiology and Drug Safety. S241-S241. 2008
- Effect of a proton pump inhibitor therapeutic substitution policy in aboriginal patients in remote communities.. Clinical Pharmacology and Therapeutics. S43-S43. 2008
- Causality assessment of adverse events in oncology clinical trials: A qualitative study. Pharmacoepidemiology and Drug Safety. S181-S181. 2007
- Community-based global cardiovascular risk reduction with pharmacotherapy for modifiable risk factors in high-risk patients. Pharmacoepidemiology and Drug Safety. S200-S201. 2007
- Development and validation of an adverse event causality assessment tool for use in oncology clinical trials. Pharmacoepidemiology and Drug Safety. S180-S181. 2007
- Assessing metabolic syndrome in patients using lipid lowering therapeutics in the Canadian population.. Clinical Pharmacology and Therapeutics. S27-S28. 2007
- Enhancing signal detection for pharmacovigilance using pharmacogenomics. Pharmacoepidemiology and Drug Safety. S136-S137. 2006
- PIII-15Prioritizing treatment preferences in patients with type 2 diabetes. Clinical Pharmacology and Therapeutics. P62-P62. 2006
- PAR16 POTENTIAL PROBLEMS IN USING RCT DATA TO ESTIMATE COST-EFFECTIVENESS: RESULTS FROM AN ANALYSIS OF ETANERCEPT USE IN RHEUMATOID ARTHRITIS. Value in Health. A28-A29. 2005
- Effect of gender, age and severity of asthma attack on patterns of emergency department visits due to asthma by month and day of the week.. American Journal of Epidemiology. S67-S67. 2005
- Impact of formulary policy on thiazolidinedione (TZD) use in the ontario drug benefit (ODB) program. Clinical Pharmacology and Therapeutics. P72-P72. 2005
- Mixed or dynamic trial design: New methodology of research for pharmacogenetics and pharmacogenomics studies. Clinical Pharmacology and Therapeutics. P65-P65. 2005
- Enbrel community health outcomes study: Health outcomes from patients with rheumatoid arthritis using etanercept in a community based setting. Annals of the Rheumatic Diseases. 297-298. 2004
- Twelve-month follow-up results for the etanercept community health outcomes [ECHO] study. Annals of the Rheumatic Diseases. 421-422. 2003
- Understanding Why Physicians Modify or Ignore Prescribing Guidelines. Clinical Pharmacology and Therapeutics. P26-P26. 2003
- Impact of etanercept (Enbrel (R)) on employment and functional status in a community setting (the Enbrel (R) community health outcomes [ECHO) study).. Arthritis and Rheumatism. S531-S531. 2002
- An evaluation of the number and types of recommendations made by a clinical pharmacologist and pharmacist in an ambulatory consultation service.. Clinical Pharmacology and Therapeutics. P78-P78. 2002
- Drug-herb interaction among commonly used conventional medicines: Development of a desk reference for health care professionals.. Clinical Pharmacology and Therapeutics. P58-P58. 2002
- Etanercept Community Health Outcomes study (ECHO).. Clinical Pharmacology and Therapeutics. P91-P91. 2002
- Patterns of use of natural health products by Ontario seniors.. Clinical Pharmacology and Therapeutics. P14-P14. 2001
- Providing evidence-based information to patients: Impact on physician prescribing.. Clinical Pharmacology and Therapeutics. P93-P93. 2001
- The use of natural health products (NHP) by Ontario seniors.. Clinical Pharmacology and Therapeutics. P14-P14. 2001
- Patient and clinician perception of patient medication information needs.. Clinical Pharmacology and Therapeutics. 140-140. 2000
- Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs.. Clinical Pharmacology and Therapeutics. 153-153. 2000
- An evaluation of the quality of herbal remedy information provided by health food store retailers and pharmacists. Clinical Pharmacology and Therapeutics. 174-174. 1999
- Instruments measuring clinical benefit: Who knows best, patient or instrument. Clinical Pharmacology and Therapeutics. 173-173. 1999
- Alendronate co-medications may limit its use.. Clinical Pharmacology and Therapeutics. 197-197. 1998
- Intrapatient variability in response to NSAID therapy for rheumatoid arthritis.. Clinical Pharmacology and Therapeutics. 168-168. 1998
- Quality of life of asthma and bronchitis patients as diagnosed from telephone interview data. Quality of Life Research. 139-139. 1997
- Drug price awareness survey of Ontario physicians.. Clinical Pharmacology and Therapeutics. PII90-PII90. 1996
- Treatment of chronic atrial fibrillation with warfarin or aspirin: A cost-effectiveness and cost-utility analysis.. Clinical Pharmacology and Therapeutics. PII89-PII89. 1996
- Economic evaluation of Helicobacter pylori eradication in the management of duodenal ulcer. HELICOBACTER PYLORI. 384-397. 1996
- Health-Related Quality of Life in Patients With Major Depression Who Are Treated With Moclobemide. Journal of Clinical Psychopharmacology. 60S-67S. 1995
- EFFECT OF A POLICY TO REDUCE PHYSICIAN PRESCRIBING OF SUSTAINED-RELEASE (SR) NSAID FORMULATIONS. Clinical Pharmacology and Therapeutics. 147-147. 1995
- RCT OF POSTMARKETING SURVEILLANCE METHODS. Clinical Pharmacology and Therapeutics. 147-147. 1995
- USE OF VARIOUS INDEXES IN POPULATION-BASED SCREENING FOR THALASSEMIA - UTILITY OF THE MEAN CORPUSCULAR VOLUME. Blood. A555-A555. 1994
- EVALUATION OF PROGRAMS TO EDUCATE AND INFORM THE ELDERLY IN THE RESPONSIBLE USE OF MEDICATIONS. Clinical Pharmacology and Therapeutics. 190-190. 1993
- EVALUATING RISK-BENEFIT IN DRUG TRIALS. Clinical Pharmacology and Therapeutics. 126-126. 1992
- HALOTHANE ANESTHESIA AND HEPATIC-INJURY. Clinical Pharmacology and Therapeutics. 125-125. 1992
- ADVERSE SYMPTOMS INDEX. Clinical Pharmacology and Therapeutics. 151-151. 1991
- THE EFFECT OF SUCRALFATE AND FOOD ON IBUPROFEN ENANTIOMER BIOAVAILABILITY. Clinical Pharmacology and Therapeutics. 193-193. 1990
- PHARMACOKINETIC INTERACTION BETWEEN NISOLDIPINE AND PROPRANOLOL. Clinical Pharmacology and Therapeutics. 207-207. 1986
- PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN NISOLDIPINE AND PROPRANOLOL. Clinical and Investigative Medicine. A17-A17. 1986